CLL-211 Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin Lymphoma (NHL): Results From a Large, Single-Center Observational Study

Context: CLL and indolent NHL are hematologic malignancies that typically result in immune dysfunction. Infection represents a major cause of morbidity and mortality in these patients. Patients with CLL and NHL are at higher risk of hospitalization and death from COVID-19.3 Data is lacking regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: St-Pierre, Frédérique, Doukas, Peter, Boyer, Jennifer, Nieves, Mariana, Ma, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acute Lymphoblastic Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489270/
http://dx.doi.org/10.1016/S2152-2650(22)01335-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489270/
http://dx.doi.org/10.1016/S2152-2650(22)01335-0

Ejemplares similares